Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy

NCT05451420 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: PegIFN α- 2b

Sponsor

Henan Provincial People's Hospital

Collaborators

[object Object]